Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in β-thalassemia intermedia patients

References

• Vigi V., Volpato S., Gaburro D., Conconi F., Bargellesi A., Pontremoli S. The correlation between red-cell survival and excess of α-globin synthesis in β-thalassemia. British Journal of Hematology 1969; 16: 25–30
   PubMed Web of Science ®Google Scholar
• Gerli G.C., Beretta L., Bianchi M. Erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities in β-thalassemia (major and minor). Scandinavian Journal of Hematology 1980; 25: 87–92
   PubMedGoogle Scholar
• Kahane I. Cross-linking of red blood cell membrane proteins induced by oxidative stress in β-thalassemia. FEBS Letters 1978; 85: 267–270
   PubMed Web of Science ®Google Scholar
• Rachmilewitz E.A., Shinar E., Shalev O., Galili U., Schrier S.L. Erythrocyte membrane alterations in β-thalassemia. Clinics in Hematology 1985; 14: 163–182
   PubMedGoogle Scholar
• Shinar E., Rachmilewitz E.A. Oxidative denaturation of red blood cells in thalassemia. Seminars in Hematology 1990; 27: 70–82
   PubMed Web of Science ®Google Scholar
• Chiu D.T-Y., Van den Berg J., Kuypers F.A., Hung I-J., Wei J-S., Liu T-Z. Correlation of membrane lipid peroxidation with oxidation of hemoglobin variants: possibly related to the rates of hemin release. Free Radical Biology and Medicine 1996; 21: 89–95
   PubMed Web of Science ®Google Scholar
• Van Dyke B.R., Saltman P. Hemoglobin: a mechanism for the generation of hydroxyl radicals. Free Radical Biology and Medicine 1996; 20: 985–989
   PubMed Web of Science ®Google Scholar
• Grinberg L.N., Rachmilewitz E.A., Kitrossky N., Chevion M. Hydroxyl radical generation in β-thalassemic red blood cells. Free Radical Biology and Medicine 1995; 18: 611–615
   PubMed Web of Science ®Google Scholar
• Scott M.D., Van den Berg J.J.M., Repka T., Rouyer-Fessard P.H., Hebbel R.P., Beuzard Y., Lubin B. Effect of excess α-hemoglobin chains on cellular and membrane oxidation in model β-thalassemic erythrocytes. Journal of Clinical Investigation 1993; 91: 1706–1712
   PubMed Web of Science ®Google Scholar
• Livrea M.A., Tesoriere L., Maggio A., D'Arpa D., Pintaudi A.M., Pedone E. Oxidative modification of low-density lipoprotein and atherogenetic risk in β-thalassemia. Blood 1998; 92: 3936–3942
   PubMed Web of Science ®Google Scholar
• Keany J.F., jr, Frey B. Antioxidant protection of low-density lipoproteins and its role in the prevention of atherosclerotic vascular disease. Natural Antioxidants in Human Health and disease, B. Frey. Academic Press, San Diego, CA 1994; 303–357, in
   Google Scholar
• Gaziano J.M., Manson J.E., Hennekens C.H. Natural antioxidants and cardiovascular disease: observational epidemiologic studies and randomized trials. Natural Antioxidants in Human Health and Disease, B. Frey. Academic Press, San Diego, CA 1994; 387–409, In
   Google Scholar
• Esterbauer H., Schmidt R., Hayn M. Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. Advances in Pharmacology, H. Sies. Academic Press, San Diego, CA 1997; 425–456, In
   Google Scholar
• Jialal I., Fuller C.J., Huet B.A. The effect of α-tocopherol supplementation on LDL oxidation. A dose-response study. Arteriosclerosis, Thrombosis, and Vascular Biology 1995; 15: 190–198
   PubMed Web of Science ®Google Scholar
• Belcher J.D., Balla J, Balla G., Jacobs D.R., Jr., Gross M., Jacob H.S., Vercellotti G.M. Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Atherosclerosis and Thrombosis 1993; 13: 1779–1789
   PubMed Web of Science ®Google Scholar
• Bendich A., Machlin L.J. The safety of oral intake of vitamin E: data from clinical studies from 1986 to 1991. Vitamin E in Health and Disease, L. Packer, J. Fuchs. Marcel Dekker, Inc, New York, NY 1993; 411–416, In
   Google Scholar
• Meydani S.N., Meydani M., Blumberg J.B., Leka L.S., Pedrosa M., Diamond R., Schaefer E.J. Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. American Journal of Clinical Nutrition 1998; 68: 311–318
   PubMed Web of Science ®Google Scholar
• Pryor W.A. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radical Biology and Medicine 2000; 28: 141–164
   PubMed Web of Science ®Google Scholar
• Friedwald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of LDL-cholesterol in plasma without use of preparative ultracentrifuge. Clinical Chemistry 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Kleinveld H.A., Hak-Lemmers H.L.M., Stalenhoef A.F.H., Demaker P.N.M. Improved measurement of low density lipoprotein susceptibility to copper-induced oxidation: Application of a short procedure for isolating low-density lipoprotein. Clinical Chemistry 1992; 38: 2066–2072
   PubMed Web of Science ®Google Scholar
• Bradford M.M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Buege J.A, Aust S.D. Microsomal lipid peroxidation. Methods in Enzymology, S. Fleischer, L. Packer. Academic Press, New York, NY 1978; 52: 302–310, In
   Google Scholar
• Pryor W.A., Castle L. Chemical methods for detection of lipid hydroperoxides. Methods in Enzymology, L. Packer. Academic Press, Orlando, FL 1984; 105: 293–299, In
   Google Scholar
• Kraft N.E. Carotenoid reversed-phase high performance liquid chromatography methods: Reference compendium. Methods in Enzymology, L. Packer. Academic Press, San Diego, CA 1992; 213: 185–205, In
   Google Scholar
• Lazzarino G, Di Pierro D., Tavazzi B., Cerroni L., Giardina B. Simultaneous separation of malondialdehyde, ascorbic acid, and adenine nucleotide derivatives from biological sample by ion-pairing high-performance chromatography. Analytical Biochemistry 1991; 197: 191–196
   PubMed Web of Science ®Google Scholar
• Rachmilewitz E.A., Shifter A., Kahane I. Vitamin E deficiency in β-thalassemia major: changes in hematological and biochemical parameters after a therapeutical trial with α-tocopherol. American Journal of Clinical Nutrition 1979; 32: 1850–1858
   PubMed Web of Science ®Google Scholar
• Kahane I., Rachmilewitz E.A. Alterations in red blood cell membrane and the effect of vitamin E on osmotic fragility in β-thalassemia major. Israel Journal of Medical Sciences 1976; 12: 11–15
   PubMedGoogle Scholar
• Giardini O., Cantani A., Donfrancesco A., Martino F., Mannarino O., D'Eufemia P., Miano C., Ruberto U., Lubrano R. Biochemical and clinical effects of vitamin E administration in homozigous beta-thalassemia. Acta Vitaminologica et Enzymologica 1985; 7: 55–60
   PubMedGoogle Scholar
• Bianco L., Boccaccini R., Capalbo P., Morici G., Maestro M., Mandrino M. The role of vitamin E in the therapy of thalassemia. Pediatria Medica e Chirurgica 1986; 8: 23–26
   PubMedGoogle Scholar
• Modell C.B., Stock J., Dormandy T.L. Vitamin E in thalassemia. British Medical Journal 1974; 3: 259–259
   PubMedGoogle Scholar
• Hyman C.B., Landing B., Alfin-Slater R., Kozak L., Weitzman J., Ortega J.A. d-1-α tocopherol, iron and lipofuscin in thalassemia. Annals of the New York Academy of Science 1974; 232: 211–220
   PubMed Web of Science ®Google Scholar
• Zannos-Mariolea L., Tzortzatou F., Dendaki-Svolaki K., katerllos C., Kavallari M., Matsaniotis N. Serum vitamin E levels with beta-thalassemia major: preliminary report. British Journal of Haematology 1974; 26: 193–199
   PubMed Web of Science ®Google Scholar
• Zannos-Mariolea L., Papagregoriou-Theodoridou M., Costanzas N., Matsaniotis N. Relationship between tocopherols and serum lipid levels in children with β-thalassemia major. American Journal of Clinical Nutrition 1978; 31: 259–263
   PubMed Web of Science ®Google Scholar
• Livrea M.A., Tesoriere L., Pintaudi A.M., Calabrese A., Maggio A., Freisleben H-J., D'Arpa D., D'Anna R., Bongiorno A. Oxidative stress and antioxidant status in β-thalassemia major: iron overload and depletion of lipid soluble antioxidants. Blood 1996; 88: 3608–3614
   PubMed Web of Science ®Google Scholar
• De Luca C., Filosa A., Grandinetti M., Maggio F., Lamba M., Passi S. Blood antioxidants status and urinary levels of catecholamine metabolites in β-thalassemia. Free Radical Research 1999; 30: 453–462
   PubMed Web of Science ®Google Scholar
• Rachmilewitz E.A., Lubin B.H., Shohet S.B. Lipid membrane peroxidation in β-thalassemia major. Blood 1976; 47: 495–505
   PubMed Web of Science ®Google Scholar
• Stocker R., Frei B. Endogenous antioxidant defences in human blood plasma. Oxidants and Antioxidants, H. Sies. Academic Press, New York, NY 1991; 213–243, In
   Google Scholar
• Jacob R.A. The integrated antioxidant system. Nutrition Research 1995; 15: 755–759
   Web of Science ®Google Scholar
• Traber M.G., Lane J.C., Lagmay N.R., Kayden H.J. Studies on the transfer of tocopherol between lipoproteins. Lipids 1992; 27: 657–663
   PubMed Web of Science ®Google Scholar
• Traber M.G., Sies H. Vitamin E in humans demand and delivery. Annual Review of Nutrition 1996; 16: 321–347
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge J.M.C. Free Radicals in Biology and MedicineThird Edition. Oxford University Press, Oxford 1999
   Google Scholar
• Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radical Biology and Medicine 1991; 11: 81–121
   PubMed Web of Science ®Google Scholar
• Marnett L.J. Lipid peroxidation-DNA damage by malondialdehyde. Mutation Research 1999; 424: 83–95
   PubMed Web of Science ®Google Scholar
• Slatter D.A., Gordon P.R., Murray M., Bailey A.J. Reaction of lipid-derived malondialdehyde with collagen. Journal of Biological Chemistry 1999; 274: 19661–19669
   PubMed Web of Science ®Google Scholar
• Holvoet P., Perez G., Zhao Z., Brouwers E., Bernar H., Collen D. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. Journal of Clinical Investigation 1995; 95: 2611–2619
   PubMed Web of Science ®Google Scholar
• Steinberg D., Parthasaraty S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modification of low density lipoprotein that increase atherogenicity. New England Journal of Medicine 1989; 320: 915–924
   PubMed Web of Science ®Google Scholar
• Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radical Biology and Medicine 1996; 20: 707–727
   PubMed Web of Science ®Google Scholar
• Schawartz C.J., Valente A.J. The pathogenesis of atherosclerosis. Natural antioxidants in Human Health and Disease, B. Frei. Academic Press, San Diego, CA 1994; 287–302, In
   Google Scholar
• Pentikäinen M.O., Öörni K., Ala-Korpela M., Kovanen P.T. Modified LDL — trigger of atherosclerosis and inflammation in the arterial intima. Journal of Internal Medicine 2000; 247: 359–370
   PubMed Web of Science ®Google Scholar
• Paganga G., Rice-Evans C., Rule R., Leake D. The interaction between ruptured erythrocytes and low density lipoproteins. FEBS Letters 1992; 303: 154–158
   PubMed Web of Science ®Google Scholar
• Altamentova S.M., Marva E., Shaklai N. Oxidative interaction of unpaired hemoglobin chains with lipids and proteins: a key for modified serum lipoproteins in thalassemia. Archives of Biochemistry and Biophysics 1997; 345: 39–46
   PubMed Web of Science ®Google Scholar
• Sonakul D., Suwanagool P., Sirivaidyapong P., Fucharoen S. Distribution of pulmonary thromboembolism lesions in thalassemic patients. Birth Defects 1988; 23(5A)375–384
   Google Scholar
• Wong V., Yu Y., Laing R.H.S., Tso WK., Li AMC., Chan TK. Cerebral thrombosis in β-thal/Hb disease. Stroke 1990; 21: 812–816
   PubMed Web of Science ®Google Scholar
• Pascher F., Keen R. Ulcer legs in Cooley's anemia. New England Journal of Medicine 1957; 256: 1220–1222
   PubMedGoogle Scholar
• Butthep P., Bunyaratvej A., Funahara Y., Kitaguchi H., Fucharoen S., Sato S., Bhamarapravati N. Alterations in vascular endothelial cell-related plasma proteins in thalassaemic patients and their correlation with clinical symptoms. Thrombosis and Haemostasis 1995; 74: 1045–1249
   PubMed Web of Science ®Google Scholar
• Manfre' L., Giarratano E., Maggio A., Banco A., Vaccaro G., Lagalla R. NMR Imaging of the brain: Findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. American Journal of Roentgenology 1999; 173: 1477–1480
   PubMed Web of Science ®Google Scholar
• Lynch S.M., Frey B. Antioxidants as antiatherogens: animal studies. Natural Antioxidants in Human Health and disease, B. Frey. Academic Press, San Diego, CA 1994; 353–385, In
   Google Scholar
• Dowd P., Zheng Z.B. On the mechanism of the anticlotting action of vitamin E quinone. Proceedings of National Academy of Science 1995; 92: 8171–8175
   PubMed Web of Science ®Google Scholar
• Calzada C., Bruckdorfer K.R., Rice-Evans C.A. The influence of antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis 1997; 128: 97–105
   PubMed Web of Science ®Google Scholar
• Tasinato A., Boscoboinik D., Bartoli G.M., Maroni P., Azzi A. d-α-Tocopherol inhibition of vascular smooth cell proliferation occurs at physiological concentration, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proceedings of National Academy of Science 1995; 92: 12190–12194
   PubMed Web of Science ®Google Scholar
• Teupser D., Thiery J., Seidel D. α-Tocopherol down-regulates scavenger receptor activity in macrophages. Atherosclerosis 1999; 144: 109–115
   PubMed Web of Science ®Google Scholar
• Martin A., Foxall T., Blumberg J.B., Meydani M. Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. Arteriosclerosis, Thrombosis, and Vascular Biology 1997; 17: 429–435
   PubMed Web of Science ®Google Scholar